Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
50
Number of overlapping holdings
24.9%
% of IBB's 219 holdings also in BBP
96.2%
% of BBP's 55 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 8.2% | 2.0% | 2.0% |
|
MODERNA, INC. | 3.5% | 2.0% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 8.1% | 1.9% | 1.9% |
|
AMGEN INC | 8.3% | 1.8% | 1.8% |
|
BIOMARIN PHARMACEUTICAL INC | 1.6% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to BBP
|
GILEAD SCIENCES INC | 6.5% |
|
AMGEN INC | 6.4% |
|
VERTEX PHARMACEUTICALS INC | 6.2% |
|
REGENERON PHARMACEUTICALS | 6.2% |
|
IQVIA HOLDINGS INC | 4.4% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.8% |
|
ILLUMINA INC | 2.1% |
|
WATERS CORP | 2.0% |
 |
ARGENX SE ADR | 2.0% |
 |
GENMAB A/S SPONSORED ADR | 1.7% |
IBB Underweight Relative to BBP
|
LEXICON PHARMACEUTICALS, INC. | -3.4% |
|
TARSUS PHARMACEUTICALS, INC. | -3.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.4% |
|
AGIOS PHARMACEUTICALS INC | -2.3% |
|
ADMA BIOLOGICS, INC. | -2.3% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.3% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.2% |
|
LIGAND PHARMACEUTICALS-CL B | -2.0% |
|
DECIPHERA PHARMACEUTICALS, INC. | -1.9% |
|
PTC THERAPEUTICS INC | -1.9% |